BIOTECanada :: Keep Canada Competitive

Advocacy & Policy

Keep Canada Competitive

News

Senate Committee Study on Prescription Pharmaceuticals

The Senate Standing Committee on Social Affairs, Science and Technology, chaired by the Honourable Senator Ogilvie has been examining prescription pharmaceuticals in Canada.

This study is studying the following:

the process to approve prescription pharmaceuticals with a particular focus on clinical trials;
the post-approval monitoring of prescription pharmaceuticals;
the off-label use of prescription pharmaceuticals; and
the nature of unintended consequences in the use of prescription pharmaceuticals.

BIOTECanada has been participating in the committee appearances by showcasing the leadership of our members in this area.

In April, we discusses clinical trials - read the remarks here.

In October, we discussed post approval monitoring
Andrew Casey's remarks
Loretta Del Bosco's remarks

Bio-Economy Roundtable 2012

The biotechnology industry in Canada is at the core of economic opportunity for a vast array of health, manufacturing, environmental, and agricultural technologies. From the recent growth of bio fuels for jets, to the integration of composite bio materials in homes and cars, biotechnology innovation is redefining traditional industries to the benefit of Canadians in all regions of the country. Despite the recent economic downturn, the biotechnology sector still grew by 12% over the past four years, one of the few sectors that saw growth during the downturn.

Innovative Biotechnology Leaders Welcome The Federal Budget Announcements For New Investments

OTTAWA, ON Canada’s biotech industry was pleased to see the proposed $400 million to support creation of new large scale VC funds, $100 million for the Business Development Bank of Canada for VC activities, and the Industrial Research Assistance Program being doubled to $110 annually. Creating these incentives will facilitate investment into Canada’s emerging biotech industry. Read the news release here.

Background Information
Industry Financing - Pre-budget 2012 consultations

A submission to the House of Commons Standing Committee on Finance to create sustainable long-term economic growth in Canada.

Download the submission here.

John Hyshka, CFO Phenomenome presented to the Standing Committee on FInance. Download his remarks here.

Response to Jenkins Report

Anthony Giovinazzo, Chair of BIOTECanada's Emerging Companies Advisory Board and Peter Brenders, President and CEO of BIOTECanada have co-signed our response to the Expert Panel on Research and Development. Read it here.

Together with the Canadian Manufacturers & Exporters along with others we have signed onto a letter for Minister Goodyear concerning the recommendations from the recent Expert Panel on Research and Development. Read it here.

Print This Page